Skip to main content
On Demand

Nephrology for the Primary Care Provider


Total Credits: .5 including .5 AOA Category 1-A Credit(s)

Average Rating:
   13
State Associations:
VOMA - Virginia
Faculty:
Corey Cavanaugh, DO
Duration:
40 Minutes
Expiration:
Never expires.


Description

Chronic kidney disease (CKD) is a common, yet under recognized problem in America.  In the last 5 years, a number of studies have been published describing new therapies to combat CKD and lower the rate of end stage kidney disease.  This presentation will cover these studies regarding SGLT2 inhibitors, mineralocorticoid receptor antagonists, and GLP-1  agonists to name a few. The goal is to provide practical and concise information, such that physician inertia in prescribing these therapies can be overcome.

Learning Objectives

Following the completion of this lecture, the participant will be able to:

  1. Discuss the use of SGLT2 inhibitors in CKD
  2. Discuss the role of mineral corticoid receptor antagonists in CKD
  3. Discuss the role of GLP-1 agonists in CKD
  4. Review the relevant labs that need to be check when confronting CKD in the outpatient setting 

Handouts

Faculty

Corey Cavanaugh, DO's Profile

Corey Cavanaugh, DO Related Seminars and Products


Dr. Cavanaugh is a nephrologist specializing in glomerular diseases or diseases that impact the kidneys. These include lupus, vasculitis, membranous nephropathy and focal segmental glomerulosclerosis (FSGS), among others.

Cavanaugh attended medical school at the Heritage College of Osteopathic Medicine at Ohio University, where he met his wife. They both completed their internal medicine training at the University of Louisville. Cavanaugh then went on to pursue a nephrology fellowship at Yale University before settling in Virginia. Since arriving at the University of Virginia in August of 2019, he has
established a dedicated multidisciplinary glomerular disease clinic,    as well as a combined rheumatology-nephrology clinic.  

Dr. Cavanaugh has no disclosures


Accreditation Information

The Virginia Osteopathic Medical Association (VOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. VOMA designates this program for a maximum of 1 AOA Category 1A CME credits and will report CME credits commensurate with the extent of the physician’s participation.

​Grievances regarding program administration and reporting of AOA CME credits will be handled on an individual basis Initially, all grievances should be directed to VOMA Executive Director. Participants with grievances that cannot be resolved will be sent to the AOA Council on CME , 142 East Ontario Street, Chicago, IL 60611.

Reviews

5
4
3
2
1

Overall:      4.6

Total Reviews: 13